医学
苯二氮卓
毒物控制
人为因素与人体工程学
伤害预防
职业安全与健康
自杀预防
急诊医学
管辖权
医疗急救
环境卫生
重症监护医学
麻醉
毒性
梅德林
精神科
作者
Shane Darke,Johan Duflou,Michael Farrell,Julia Lappin,Amy Peacock
标识
DOI:10.1016/j.drugalcdep.2026.113085
摘要
BACKGROUND: Deaths due to poisoning involving novel benzodiazepines (NBZDs) are increasing. We aimed to determine: 1. The characteristics, toxicology and major autopsy findings of known cases of NBZD-related poisoning in Australia, 2000-2025; and 2. Changes in characteristics of known cases from 2020 onwards compared to earlier known cases. METHODS: Retrospective study of fatal NBDZ-related poisoning in Australia retrieved from the National Coronial Information System. RESULTS: 258 cases were identified, the first in 2013 (2013-2019: 33, 2020-2025: 225). The mean age was 31.9 years and 217 were male, which did not change. 2020s cases were more likely to have histories of injecting drug use (52.0v 21.2 %, OR 4.0) and mental health issues (55.1v 30.3 %, OR 2.8). Fifteen NBZDs were detected, nine first detected in the 2020s. The most frequent were etizolam (48.9 %) and bromazolam (38.0 %). Cases in the later period were more likely to have multiple NBZDs detected (39.6v 12.1 %, OR 4.7). The most common other drug classes were opioids (74.8 %) and registered hypnosedatives (62.4 %). There were no differences between cases in the later and earlier periods in the presence of depressants (94.7v 93.9 %), or psychostimulants (52.0v 39.4 %). Acute bronchopneumonia was less common in the later period (18.2v 40.0 %, OR 1.5). CONCLUSIONS: The 2020s saw a large increase in poisoning deaths related to NBZDs. As testing varied across time and jurisdiction and new NBZDs are constantly appearing the true extent of NBZD-related poisoning deaths is likely to be higher than those identified.
科研通智能强力驱动
Strongly Powered by AbleSci AI